ClinicalTrials.Veeva

Menu

Endodontic Treatment of Primary Teeth With Guedes-Pinto Paste Without Antibiotic

U

University of Sao Paulo

Status and phase

Completed
Phase 3

Conditions

Pulp Disorder

Treatments

Drug: Endodontic using Guedes-Pinto Paste without antibiotic
Drug: Endodontic treatment using Guedes-Pinto Paste

Study type

Interventional

Funder types

Other

Identifiers

NCT03839485
FouspPGP

Details and patient eligibility

About

The pulp therapy in primary teeth is still necessary even with all odontopediatrics evolution in prevention and minimal intervention, aiming to keep the tooth free of inflammation or infection and in a functional state until its exfoliation. Several materials are used as filling paste of primary teeth. In Brazil, the Guedes-Pinto Paste (PGP), an association of iodofórmio, camphorated paramonochlorophenol, prednisolone and rifamycin, has been widely used for some decades. However, current Brazilian legislation has made it difficult to commercialize antibiotics, which has made it difficult to obtain the ointment that is the association between prednisolone and rifamycin. Therefore, the objective of this clinical trial will be to test PGP without rifamycin in the pulpectomy of primary teeth, and to compare it with the treatment performed with conventional PGP.

Full description

A randomized triple-blind non-inferiority clinical study with two parallel arms, with a 12-month follow-up, will be performed. The experimental group will be PGP formulated without the antibiotic, while the control group is the conventional PGP, containing rifamycin. The conventional pulpectomy will be performed using manual files, performing the instrumentation aided by Endo-PTC and 1% sodium hypochlorite. At the end of the instrumentation, just before the obturation, the groups will be drawn, with the strategy of randomization in permuted blocks and stratified by the initial condition of the tooth (with or without periapical lesion). The main outcome will be the clinical and radiographic success of endodontic treatment after 12 months. Patients who seek the dental service of the municipality and require endodontic treatment will be invited to participate in the study. The data will be statistically analyzed using the statistical package Stata 12.0 (Stata Corporation, College Station, TX, USA). The longevity of the treatments will be evaluated by estimating survival rates using the Kaplan-Meier method. The differences between survival rates according to the type of endodontic treatment proposed will be analyzed through the Log-rank test.

Enrollment

100 patients

Sex

All

Ages

4 to 8 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Primary molar teeth with necessity of endodontic treatment.
  • Patients whose parents or guardians consent to their participation in the study

Exclusion criteria

  • Systemic health problems, congenital facial deformities, facial tumors or syndromes

  • Teeth presenting one of the following:

    • Resorption of more than 2/3 of the root
    • Destruction of the crypt of the permanent successor
    • Pulp chamber floor drilling.
    • Presence of internal resorption

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

100 participants in 2 patient groups

Pasta Guedes-Pinto
Active Comparator group
Description:
Endodontic treatment using Guedes-Pinto Paste
Treatment:
Drug: Endodontic treatment using Guedes-Pinto Paste
Pasta Guedes-Pinto without antibiotic
Experimental group
Description:
Endodontic using Guedes-Pinto paste without antibiotic
Treatment:
Drug: Endodontic using Guedes-Pinto Paste without antibiotic

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems